Influence of glucagon‐like peptide‐1 receptor agonists on hepatic events in type 2 diabetes: a systematic review and meta‐analysis

Documenti analoghi

• PCED1A as a Predictive Biomarker for Immunotherapy and Anti‐Angiogenic Treatment in Hepatocellular and Colorectal Cancer
  di: Valbert Oliveira Costa Filho, et al.
  Pubblicazione: (2025)
• Optimizing Model Construction and Ideal Cutoff Mechanisms in Targeted Screening for Autoimmune Gastritis
  di: Pedro Robson Costa Passos, et al.
  Pubblicazione: (2025)
• Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells
  di: Xixi Zeng, et al.
  Pubblicazione: (2024)
• Adverse events in endoscopic ultrasound‐guided choledochoduodenostomy with lumen‐apposing metal stents: A systematic review and meta‐analysis
  di: Jia‐Su Li, et al.
  Pubblicazione: (2024)
• Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
  di: Qi‐Hang Cao, et al.
  Pubblicazione: (2024)